Elrexfio 40 mg/mL injection Images
Generic Name: elranatamab
This medication has been identified as Elrexfio 40 mg/mL injection. It is supplied by Pfizer Inc.
Elrexfio is used in the treatment of Multiple Myeloma and belongs to the drug class miscellaneous antineoplastics. Elrexfio 40 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Elrexfio
- Generic Name
- elranatamab
- Strength
- 40 mg/mL injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
More about Elrexfio (elranatamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
